Advertisement

Topics

GSK's new pharma chief Miels to join in September

07:38 EDT 20 Jun 2017 | pharmaphorum

GlaxoSmithKline’s new head of pharmaceuticals, Luke Miels, will start work in September, after the company settled a contract dispute with UK rivals AstraZeneca. GSK poached Miels from AstraZeneca in January, but his appointment was stalled beca...

Original Article: GSK's new pharma chief Miels to join in September

NEXT ARTICLE

More From BioPortfolio on "GSK's new pharma chief Miels to join in September"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...